Voûte PA - Search Results

1

[131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.

Hoefnagel CA, Voûte PA, De Kraker J, Valdés Olmos RA. Hoefnagel CA, et al. Among authors: voute pa. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):202-6. J Nucl Biol Med (1991). 1991. PMID: 1823819

2

Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine.

Hoefnagel CA, Voûte PA, de Kraker J, Marcuse HR. Hoefnagel CA, et al. Among authors: voute pa. J Nucl Med. 1987 Mar;28(3):308-14. J Nucl Med. 1987. PMID: 3102701 Free article.

3

131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.

Voûte PA, Hoefnagel CA, de Kraker J. Voûte PA, et al. Bull Cancer. 1988;75(1):107-11. Bull Cancer. 1988. PMID: 3359053

4

Side effects of treatment with I-131-meta-iodobenzylguanidine (I-131-MIBG) in neuroblastoma patients.

Voûte PA, Hoefnagel CA, de Kraker J, Majoor M. Voûte PA, et al. Prog Clin Biol Res. 1988;271:679-87. Prog Clin Biol Res. 1988. PMID: 3406024 No abstract available.

5

Radionuclide therapy of neural crest tumors.

Voûte PA, Hoefnagel CA, de Kraker J, Evans AE, Hayes A, Green A. Voûte PA, et al. Med Pediatr Oncol. 1987;15(4):192-5. doi: 10.1002/mpo.2950150410. Med Pediatr Oncol. 1987. PMID: 3657706

6

Clinical experience with radiation enhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage IV.

Voûte PA, van der Kleij AJ, De Kraker J, Hoefnagel CA, Tiel-van Buul MM, Van Gennip H. Voûte PA, et al. Eur J Cancer. 1995;31A(4):596-600. doi: 10.1016/0959-8049(95)00073-r. Eur J Cancer. 1995. PMID: 7576976 Clinical Trial.

7

First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.

De Kraker J, Hoefnagel CA, Caron H, Valdés Olmos RA, Zsiros J, Heij HA, Voûte PA. De Kraker J, et al. Among authors: voute pa. Eur J Cancer. 1995;31A(4):600-2. doi: 10.1016/0959-8049(95)00063-o. Eur J Cancer. 1995. PMID: 7576977 Clinical Trial.

8

131I-MIBG as a first-line treatment in high-risk neuroblastoma patients.

Hoefnagel CA, De Kraker J, Valdés Olmos RA, Voûte PA. Hoefnagel CA, et al. Among authors: voute pa. Nucl Med Commun. 1994 Sep;15(9):712-7. doi: 10.1097/00006231-199409000-00008. Nucl Med Commun. 1994. PMID: 7816384 Clinical Trial.

9

Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.

van Hasselt EJ, Heij HA, de Kraker J, Vos A, Voûte PA. van Hasselt EJ, et al. Among authors: voute pa. Eur J Pediatr Surg. 1996 Jun;6(3):155-8. doi: 10.1055/s-2008-1066495. Eur J Pediatr Surg. 1996. PMID: 8817208

10

[131I]MIBG as a first line treatment in advanced neuroblastoma.

Hoefnagel CA, De Kraker J, Valdés Olmos RA, Voûte PA. Hoefnagel CA, et al. Among authors: voute pa. Q J Nucl Med. 1995 Dec;39(4 Suppl 1):61-4. Q J Nucl Med. 1995. PMID: 9002752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters